Heart drug study pulled before it started: no data collected
NCT ID NCT04510792
First seen Jan 02, 2026 · Last updated May 10, 2026 · Updated 16 times
Summary
This study was designed to find out how often high potassium levels (hyperkalemia) cause doctors to reduce or stop important heart medications called RAAS inhibitors in emergency room or hospitalized patients. The goal was to understand how common this problem is and whether new potassium-lowering drugs could help keep patients on their heart medications. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERKALEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital
Portsmouth, Hampshire, PO6 3LY, United Kingdom
Conditions
Explore the condition pages connected to this study.